Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D08CKE
|
|||
Former ID |
DNC000187
|
|||
Drug Name |
Alpha-monofluoromethyl-3,4-dehydroornithine methyl ester
|
|||
Synonyms |
MFMOme; Methyl, 2-fluoromethyl-2,5-diamino-3-pentenoate; Mdl-72403; methyl (E)-2,5-diamino-2-(fluoromethyl)pent-3-enoate; 2-(Fluoromethyl)dehydroornithine methyl ester; 107742-04-1; AC1O5Q3S; SCHEMBL6361254; 2,5-Diamino-2-(fluoromethyl)-3-pentenoic acid methyl ester; 96681-91-3; .alpha.-monofluoromethyldehydroornithine methyl ester; 3-Pentenoic acid, 2,5-diamino-2-(fluoromethyl)-, methyl ester
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
Structure |
Download2D MOL |
|||
Formula |
C7H13FN2O2
|
|||
Canonical SMILES |
COC(=O)C(CF)(C=CCN)N
|
|||
InChI |
1S/C7H13FN2O2/c1-12-6(11)7(10,5-8)3-2-4-9/h2-3H,4-5,9-10H2,1H3/b3-2+
|
|||
InChIKey |
KIQXCFBLXGRXPY-NSCUHMNNSA-N
|
|||
CAS Number |
CAS 96681-91-3
|
|||
PubChem Compound ID | ||||
PubChem Substance ID |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Ornithine decarboxylase (ODC1) | Target Info | Inhibitor | [1] |
BioCyc | Putrescine biosynthesis I | |||
NetPath Pathway | TCR Signaling Pathway | |||
IL2 Signaling Pathway | ||||
TGF_beta_Receptor Signaling Pathway | ||||
Panther Pathway | Ornithine degradation | |||
CCKR signaling map ST | ||||
Pathwhiz Pathway | Spermidine and Spermine Biosynthesis | |||
Pathway Interaction Database | Validated targets of C-MYC transcriptional activation |
References | Top | |||
---|---|---|---|---|
REF 1 | Plasmodium falciparum and Plasmodium berghei: effects of ornithine decarboxylase inhibitors on erythrocytic schizogony. Exp Parasitol. 1987 Oct;64(2):237-43. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.